125 studies found for:    Open Studies | "Neuroblastoma"
Show Display Options
Rank Status Study
21 Available 131-I-MIBG Therapy for Refractory Neuroblastoma and Metastatic Pheochromocytoma
Conditions: Neuroblastoma;   Metastatic Pheochromocytoma
Interventions: Drug: 131 I-Metaiodobenzylguanidine (131 I-MIBG);   Drug: 131 I-MIBG
22 Recruiting A Pilot Study on ALK Gene Mutations in Neuroblastoma
Condition: Neuroblastoma
Intervention:
23 Unknown  Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
Conditions: Neuroblastoma;   Opsoclonus-Myoclonus
Intervention: Drug: anti-CD20 (Rituximab)
24 Recruiting A Safety/Feasibility Trial of the Addition of the Humanized Anti-GD2 Antibody (hu14.18K322A) With and Without Natural Killer Cells to Chemotherapy in Children and Adolescents With Recurrent/Refractory Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: Humanized anti-GD2 antibody;   Drug: Chemotherapy;   Other: Cytokines;   Biological: Natural killer cells
25 Recruiting Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation
Condition: Neuroblastoma
Intervention: Procedure: Reduced-intensity allogeneic hematopoietic stem cell transplantation
26 Recruiting 3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAIN
Condition: Neuroblastoma
Intervention: Genetic: iC9-GD2 T Cell Lymphocytes
27 Recruiting Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
Conditions: Neuroblastoma;   Bone Marrow, Sympathetic Nervous System
Intervention: Drug: cyclophosphamide, vincristine, topotecan ,allogeneic NK cells & 3F8
28 Recruiting A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma
Condition: Neuroblastoma
Intervention: Biological: Activated T lymphocyte
29 Unknown  Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma
Condition: Neuroblastoma
Intervention: Procedure: tandem high-dose chemotherapy
30 Recruiting High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: Metaiodobenzylguanidine (MIBG)
31 Not yet recruiting Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: Busulfan - Fludarabine - TBI
32 Recruiting 131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: 131I-MIBG , Etoposide, Melphalan, Carboplatin, Autologous Peripheral Stem Cell Transplantation
33 Unknown  Nurse Case Manager Model on Neuroblastoma Caregiver's Uncertainty
Condition: Neuroblastoma
Intervention:
34 Recruiting N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Bevacizumab;   Drug: cyclophosphamide;   Drug: zoledronic acid
35 Recruiting N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: fenretinide lipid matrix;   Drug: ketoconazole;   Other: laboratory biomarker analysis;   Other: pharmacological study
36 Recruiting Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Zoledronic Acid;   Biological: Aldesleukin
37 Available 131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol
Condition: Neuroblastoma
Intervention: Drug: Metaiodobenzylguanidine (MIBG)
38 Recruiting Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma
Conditions: Neuroblastoma;   Ewings Sarcoma;   Osteogenic Sarcoma;   Rhabdomyosarcoma;   Synovial Sarcoma
Intervention: Biological: Autologous dendritic cell vaccine with adjuvant
39 Recruiting Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory Neuroblastoma
Condition: Neuroblastoma
Intervention: Biological: Tri-virus specific cytotoxic t-cells
40 Recruiting High Risk Neuroblastoma Study 1 (1.5) of SIOP-Europe (SIOPEN)
Condition: Neuroblastoma
Interventions: Drug: Vincristine;   Drug: Aldesleukin;   Drug: ch14.18/CHO;   Drug: Carboplatin;   Drug: Etoposide;   Drug: Cisplatin;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: G-CSF;   Drug: Busulfan i.v.;   Drug: Melphalan

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years